ResearcherThe University of OsakaActive in the last 2 years
Junya Okabe
Matched on OpenAlex author ID A5112154729. Sources: OpenAlex.
Their work
- Papers
- 2
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 10
2023: 1 paper · 2024: 1 paper
Papers 2
- The relationship between observation interval and prognosis in pancreatic cancer concomitant with intraductal papillary mucinous neoplasia. Co-author DOI 10.1016/j.pan.2023.11.005↗
- Regnase-1 downregulation promotes pancreatic cancer through myeloid-derived suppressor cell-mediated evasion of anticancer immunity. Co-author DOI 10.1186/s13046-023-02831-w↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Katsuhiko Sato · 2 shared papers, 2023–2024 · strength 0.30
- Paper The relationship between observation interval and prognosis in pancreatic cancer concomitant with intraductal papillary… DOI 10.1016/j.pan.2023.11.005↗
- Paper Regnase-1 downregulation promotes pancreatic cancer through myeloid-derived suppressor cell-mediated evasion of antican… DOI 10.1186/s13046-023-02831-w↗
- Teppei Yoshioka · 2 shared papers, 2023–2024 · strength 0.30
- Paper The relationship between observation interval and prognosis in pancreatic cancer concomitant with intraductal papillary… DOI 10.1016/j.pan.2023.11.005↗
- Paper Regnase-1 downregulation promotes pancreatic cancer through myeloid-derived suppressor cell-mediated evasion of antican… DOI 10.1186/s13046-023-02831-w↗
- Tetsuo Takehara · 2 shared papers, 2023–2024 · strength 0.30
- Paper The relationship between observation interval and prognosis in pancreatic cancer concomitant with intraductal papillary… DOI 10.1016/j.pan.2023.11.005↗
- Paper Regnase-1 downregulation promotes pancreatic cancer through myeloid-derived suppressor cell-mediated evasion of antican… DOI 10.1186/s13046-023-02831-w↗
- Tadashi Kegasawa · 1 shared paper, 2024 · strength 0.16
- Kenji Ikezawa · 1 shared paper, 2024 · strength 0.16
- Kengo Matsumoto · 1 shared paper, 2024 · strength 0.16
- Motohiro Hirao · 1 shared paper, 2024 · strength 0.16
- Masaya Higashiguchi · 1 shared paper, 2023 · strength 0.14
- Kazuma Daiku · 1 shared paper, 2023 · strength 0.14
- Hidetoshi Eguchi · 1 shared paper, 2023 · strength 0.14
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.